RPC1063

Based on this post from Scorpion, I added RPC1063 to the phase 1 list. It goes after the same target as Gilenya.

http://www.businesswire.com/news/home/20110127005431/en/Receptos-Initiates-Clinical-Trials-S1P1-Agonist-Program

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: